| Role |
Name |
Disclosure |
Details |
| Author | Kerri L Marquard, MD, Fellow, Reproductive Endocrinology and Infertility, Washington University School of Medicine | Nothing to disclose | Details | | Coauthor | David Chelmow, MD, Professor of Obstetrics and Gynecology, Tufts University School of Medicine; Program Director, Tufts University Affiliated Hospitals OB/GYN Residency Program; Chair, Tufts University Health Sciences Campus Institutional Review Board | Nothing to disclose | Details | | Coauthor | Edward G Evantash, MD, Assistant Professor, Department of Obstetrics and Gynecology, Tufts University School of Medicine; Associate Division Chief of General Obstetrics and Gynecology, Director of Center for Abnormal Uterine Bleeding, Department of Obstetrics and Gynecology, Tufts Medical Center | Cytyc | Details | | Medical Editor | Thomas Michael Price, MD, Associate Professor of Reproductive Endocrinology, Director of Reproductive Fellowship Training Program, Duke University Medical Center | Clinical Advisors Group MEDA Corp Consulting Gerson Lehrman Group Advisor Roche/GSK Spokesperson | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | CME Editor | Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Hancock Medical Center | Nothing to disclose | Details | | Chief Editor | Michel E Rivlin, MD, Professor, Coordinator, Quality Assurance/Quality Improvement, Department of Obstetrics and Gynecology, University of Mississippi School of Medicine | Nothing to disclose | Details |
|